Better post-approval monitoring of devices advocated in the US
This article was originally published in RAJ Devices
Executive Summary
A more rigorous device approval process in the US may well remedy some of the concerns surrounding medical devices that have been aired by Congress, but emphasis should also be placed on post-approval monitoring, Stanford Health Policy Director Alan Garber, writing in the New England Journal of Medicine on 24 March, argues1.